Related Experiment Video
Updated: Aug 10, 2025

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
Published on: April 11, 2016
Framework for Adoption of Next-Generation Sequencing (NGS) Globally in the Oncology Area
Denis Horgan1,2, Yosr Hamdi3,4, Jonathan A Lal2,5
1European Alliance for Personalised Medicine, 1040 Brussels, Belgium.
Abstract:
Radical new possibilities of improved treatment of cancer are on offer from an advanced medical technology already demonstrating its significance: next-generation sequencing (NGS). This refined testing provides unprecedentedly precise diagnoses and permits the use of focused and highly personalized treatments. However, across regions globally, many cancer patients will continue to be denied the benefits of NGS as long as some of the yawning gaps in its implementation remain unattended. The challenges at the regional and national levels are linked because putting the solutions into effect is highly dependent on cooperation between regional- and national-level cooperation, which could be hindered by shortfalls in interpretation or understanding. The aim of the paper was to define and explore the necessary conditions for NGS and make recommendations for effective implementation based on extensive exchanges with policy makers and stakeholders. As a result, the European Alliance for Personalised Medicine (EAPM) developed a maturity framework structured around demand-side and supply-side issues to enable interested stakeholders in different countries to self-evaluate according to a common matrix. A questionnaire was designed to identify the current status of NGS implementation, and it was submitted to different experts in different institutions globally. This revealed significant variability in the different aspects of NGS uptake. Within different regions globally, to ensure those conditions are right, this can be improved by linking efforts made at the national level, where patients have needs and where care is delivered, and at the global level, where major policy initiatives in the health field are underway or in preparation, many of which offer direct or indirect pathways for building those conditions. In addition, in a period when consensus is still incomplete and catching up is needed at a political level to ensure rational allocation of resources-even within individual countries-to enable the best ways to make the necessary provisions for NGS, a key recommendation is to examine where closer links between national and regional actions could complement, support, and mutually reinforce efforts to improve the situation for patients.
Insights
Next-generation sequencing (NGS) offers precise cancer diagnoses and personalized treatments. Addressing implementation gaps through national and global cooperation is crucial for equitable patient access to these advanced medical technologies.
Area of Science:
- Oncology
- Genomics
- Personalized Medicine
Background:
- Next-generation sequencing (NGS) represents a significant advancement in cancer diagnostics and treatment.
- Despite its potential, global implementation of NGS is hindered by significant gaps, limiting patient access.
- Challenges in NGS implementation are interconnected at regional and national levels, requiring coordinated solutions.
Purpose of the Study:
- To define and explore the essential conditions for effective next-generation sequencing (NGS) implementation in cancer care.
- To provide recommendations for optimizing NGS adoption based on stakeholder and policymaker engagement.
- To develop a framework for evaluating NGS implementation maturity across different countries.
Main Methods:
- Development of a maturity framework by the European Alliance for Personalised Medicine (EAPM), focusing on demand and supply factors.
- Global expert questionnaire to assess the current status and variability of NGS implementation.
- Analysis of stakeholder input and policy initiatives at national and global levels.
Main Results:
- Significant variability observed in various aspects of NGS uptake globally.
- The study identified a need for improved understanding and interpretation to facilitate cooperation.
- A maturity framework was developed to enable self-evaluation of NGS implementation.
Conclusions:
- Strengthening links between national and global efforts is essential for improving NGS implementation.
- Coordinated actions at regional and national levels can mutually reinforce progress in cancer care.
- Addressing policy and resource allocation is critical for ensuring equitable patient access to NGS.
More Related Videos
Related Concept Videos
Next-generation Sequencing
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
RNA-seq
Before the discovery of RNA-seq, microarray-based methods and Sanger sequencing were used for transcriptome analysis. However, while...
Sanger Sequencing
Genomics

